Left Ventricular Dysfunction
📧 Sign up to get email alerts when something new happens for Left Ventricular Dysfunction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-12-20Clinical Trial Update: The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED) [Phase 3]
A Phase 3 trial evaluating acadesine for reducing cardiovascular and cerebrovascular adverse events in patients undergoing coronary artery b…
-
CLINICAL_TRIALS trial_result · 2012-06-18Clinical Trial Update: Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone [Phase 4]
Phase 4 trial evaluating whether guiding heart failure therapy by NT-proBNP levels yields different outcomes than guidance by symptoms and s…
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Use of Adult Autologous Stem Cells in Treating People 2 to 3 Weeks After Having a Heart Attack (The Late TIME Study) [Phase 2]
A Phase 2 clinical trial (Late TIME Study) evaluating autologous stem cell therapy for left ventricular dysfunction after myocardial infarct…
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation [NA]
This clinical trial evaluated the safety and feasibility of magnetic resonance imaging for patients with defibrillators and was terminated; …
-
CLINICAL_TRIALS trial_result · 2011-06-13Clinical Trial Update: Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction [Phase 2]
Phase 2 study of AZD1305 in patients with left ventricular dysfunction completed; results were posted in 2011.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-01-12FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for RAMIPRIL (ramipril) from Hikma Pharmaceuticals USA Inc., allowing a generic ramipril product to …
-
CLINICAL_TRIALS research · 2011-01-12Clinical Trial Update: Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery [Phase 1, Phase 2]
Clinical trial entry describes a Phase 1/2 study of a cell therapy in patients with chronic ischemic heart disease undergoing cardiac surger…
-
CLINICAL_TRIALS research · 2010-04-12Clinical Trial Update: Urine NT-proBNP Levels and Echocardiographic Findings in Very Low Birth Weight (VLBW) Infants
This clinical trial update reports urine NT-proBNP biomarker levels and echocardiographic findings in very low birth weight premature infant…
-
CLINICAL_TRIALS trial_result · 2009-07-14Clinical Trial Update: Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration [Phase 3]
A Phase 3 trial evaluating bone marrow-derived mononuclear cells for myocardial regeneration has completed in patients with left ventricular…
-
CLINICAL_TRIALS trial_result · 2009-06-24Clinical Trial Update: VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study [Phase 1]
Phase 1 feasibility study evaluating the iCoapsys Delivery system for valvular and ventricular improvement in patients with mitral valve reg…
-
FDA approval · 2008-04-23FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for enalapril maleate (a generic ACE inhibitor) by Heritage Pharmaceuticals (d/b/a Avet Pharmace…
-
CLINICAL_TRIALS withdrawal · 2007-11-29Clinical Trial Update: Clonidine and Left Ventricular Dysfunction
The clinical trial evaluating clonidine for left ventricular dysfunction sponsored by University Hospital, Strasbourg, has been withdrawn.
-
FDA approval · 2007-11-13FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for CAPTOPRIL (captopril), approving an additional change to the approved ANDA…